SAN DIEGO, May  04, 2026  (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of The Clorox Company (NYSE:CLX). The investigation focuses on Clorox&#39;s executive officers and

The Clorox Company Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel Investigates Clorox for Potential Securities Claims

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>SAN DIEGO, May  04, 2026  (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of The Clorox Company (NYSE:CLX). The investigation focuses on Clorox&amp;#39;s executive officers and</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Clorox&#039;s recent financial report revealed a significant decline in gross margins, leading to a lowered outlook for the year. Johnson Fistel&#039;s investigation into possible federal securities law violations could add pressure on the stock as investor confidence is shaken and losses mount.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Clorox&#039;s gross margin fell 140 basis points to 43.2%.</li><li>The company lowered gross margin expectations by an additional 250 to 300 basis points.</li><li>Supply chain costs and ERP stabilization caused margin declines.</li><li>Johnson Fistel is investigating potential securities claims against Clorox.</li><li>Clorox&#039;s stock price sharply declined following these disclosures.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Johnson Fistel, PLLP (N/A)</strong>: Law firm investigating Clorox for potential investor loss recovery and compliance issues.</li><li><strong>Clorox Company (CLX)</strong>: Facing scrutiny over declining margins and potential lawsuits could influence stock performance.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>This situation falls under &#039;Legal&#039; as it involves an investigation into potential violations of federal securities laws, affecting investor confidence and company valuation. Legal challenges may lead to financial stress and reputational damage for Clorox.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Clorox&#039;s gross margin fell significantly, impacting investor sentiment and potential class action.</li><li>The lowered full-year outlook raises concerns about future profitability and cash flow.</li><li>Stock price reacted negatively, indicating heightened volatility ahead.</li><li>Investigations into executive conduct may increase legal risks and uncertainty.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Clorox&#039;s gross margin decreased to 43.2% from 44.6% year-over-year.</li><li>The company announced a revised margin outlook decline of 250 to 300 basis points.</li><li>Clorox reported these figures on April 30, 2026.</li><li>The stock price declined sharply post-disclosure, indicating investor distress.</li><li>Investigations focus on potential compliance issues with federal securities laws.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Given ongoing investigations and negative margin outlook, CLX may face further stock declines in the near term.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>SAN DIEGO, May  04, 2026  (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/CLX">CLX</a>). The investigation focuses on Clorox's executive officers and whether investor losses may be recovered under federal securities laws.</p>  <p><strong>What if I purchased Clorox securities?</strong><br></br>If you purchased Clorox securities and suffered losses on your investment, join our investigation now: <a href="https://www.globenewswire.com/Tracker?data=hZwIfBC23dPk1egdt-RtE4D-HY7vs2bGg3brCPe5KPWhBBXRgJxyg4r9BFFCaChR4b2hP-c-OXfitrFDB4IWUHgblIm7ZxwppqYPt8HK5vD4-TzIzg-emS88Lnv6UJEGu8GS2f2OkAvsx8E_QtPL5piv2SZnJWvaK3Noj7R4ZK0=" rel="nofollow" target="_blank">Click here to join the investigation</a>.</p>  <p>Or for more information, contact Jim Baker at <a href="https://www.globenewswire.com/Tracker?data=n9K7hZHV8CJmV5eMfqmmFT4i5lVSvWn2TfoooGzvUZmge0P-SqLqu_Ubk7E83hqtA104_vvwM0iPykx7iNkSnGoIg6i0ZILayVmg4GDQhv0=" rel="nofollow" target="_blank">jimb@johnsonfistel.com</a>  or (619) 814-4471.</p>  <p>There is no cost or obligation to you.</p>  <p><strong>Background of the investigation</strong><br></br>On April 30, 2026, Clorox reported its third quarter fiscal 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed that gross margin decreased 140 basis points to 43.2%, compared to 44.6% in the prior-year period.</p>  <p>In addition, Clorox reduced its full-year fiscal 2026 gross margin outlook, stating that gross margin was now expected to decline 250 to 300 basis points, compared to the Company's prior expectation at the low end of a 50 to 100 basis point decline range. During the Company's earnings call, Clorox further disclosed that gross margin came in below expectations due to higher-than-expected supply chain costs and delayed cost savings as the Company prioritized ERP stabilization.</p>  <p>Following this disclosure, Clorox's stock price declined sharply, damaging investors.</p>  <p>In light of this disclosure, Johnson Fistel is investigating whether Clorox complied with the federal securities laws. If you suffered losses from your investment in Clorox stock, contact Johnson Fistel.</p>  <p><strong>About Johnson Fistel, PLLP &#x7C; Securities Fraud &amp; Investor Rights</strong><br></br>Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit <a href="https://www.globenewswire.com/Tracker?data=bAMU9SSg41A6n7kJastuTxkyqLXN0yfABqlMzUVAk11mLmaLJR7nKvwTsajyQyo3tUeJx8poS8tO1k_iH5NsNmtz6hb3anIUFkAoHW1g5m4=" rel="nofollow" target="_blank">www.johnsonfistel.com</a>.</p>  <p><strong>Achievements</strong><br></br>In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, reflecting the firm's effectiveness in advocating for investors and recovering approximately $90,725,000 for clients in cases where it served as lead or co-lead counsel.</p>  <p>Attorney advertising.<br></br>Past results do not guarantee future outcomes.<br></br>Services may be performed by attorneys in any of our offices.<br></br>Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.</p>  <p><strong>Contact</strong></p>  <p>Johnson Fistel, PLLP<br></br>501 W. Broadway, Suite 800<br></br>San Diego, CA 92101<br></br>James Baker, Investor Relations – or – Frank J. Johnson, Esq.<br></br>(619) 814-4471 &#x7C; <a href="https://www.globenewswire.com/Tracker?data=n9K7hZHV8CJmV5eMfqmmFT4i5lVSvWn2TfoooGzvUZnlMJTdr9jgUCgQJlhSPVyxsM662chpSAct9gDUTapOUOPu_jIkfBGkAMKHGGtma2I=" rel="nofollow" target="_blank">jimb@johnsonfistel.com</a>  &#x7C; <a href="https://www.globenewswire.com/Tracker?data=8l5p9XtCrOrm3MqVdzNa-e4vCy1BW7FroVtfvgj2IETMVBTCpGOWEUEyx8k3odXs7Bxy6HT4WJu50o75F2BktM1YdNZMMa_FUEAqHk-Mvj6rSBVXKDw_olD0c9_J_bIF" rel="nofollow" target="_blank">fjohnson@johnsonfistel.com</a> </p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTcxMjY3MSM3NTgyMDA1IzIxODE3ODk="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/OTE2MzMxZjQtZjRjNS00Yjg1LWFhOGUtMzkzNDMyZTQ3Mjc2LTExOTMzNTgtMjAyNi0wNS0wNC1lbg==/tiny/Johnson-Fistel-PLLP.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c"><img src="https://ml.globenewswire.com/media/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c/small/johnson-fistel-jpg.jpg" border="0" width="150" height="150" alt="Primary Logo"></img></a></p>

Clorox's recent financial report revealed a significant decline in gross margins, leading to a lowered outlook for the year. Johnson Fistel's investigation into possible federal securities law violations could add pressure on the stock as investor confidence is shaken and losses mount.

The Clorox Company Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News